Author

Todd Jason Green

University of Alabama at BirminghamORCID 0000-0003-1158-4710Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

Aarón Silva-SáncheziD· 1 shared Ahmed Magdy KhaliliD· 1 shared Ahmed MostafaiD· 1 shared Ana C. ChangiD· 1 shared Andrew T. DeLaitschiD· 1 shared Anna MomotiD· 1 shared Anthony P. WestiD· 1 shared Arne KroidliD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aarón Silva-SánchezORCID

Author profile →

3 papers

Recent·Most cited

ImmunologyVaccinesPeer-reviewedApr 29, 2026

Intranasal immunization with live-attenuated RSV-vectored SARS-CoV-2 vaccines elicits antigen-specific systemic and mucosal immunity and protects against viral challenge and natural infection

Davide Botta, Michael D. Schultz, Aarón Silva-Sánchez…·Frances E. Lund

This study evaluates two RSV-vectored SARS-CoV-2 vaccines, showing they induce systemic and mucosal immunity and protect against viral challenge and natural infection.

1 citation

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 5, 2025

Identification of a broad and potent V3 glycan site bNAb targeting anN332gp120 glycan-independent epitope

Lutz Gieselmann, Andrew T. DeLaitsch, Malena Rohde…·Florian Klein

This paper identifies a potent, broad neutralizing antibody targeting a glycan-independent V3 epitope on HIV-1 Env, showing enhanced neutralization potency and resistance to escape mutations.

2 citations

humanproteomics

𝕏 PostBluesky

Immunologynpj VirusesPeer-reviewedNov 14, 2024

Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang…·James J. Kobie

This study develops a monoclonal antibody that broadly neutralizes multiple SARS-CoV-2 variants, including JN.1, and shows its protective efficacy in mice.

8 citations

humanproteomics

𝕏 PostBluesky